SARS-CoV-2 Vaccination Reduces Risk of Mortality and Hospitalization in MPNs
A single-center study sought to determine the effects of SARS-CoV-2 vaccination in patients with myeloproliferative neoplasms.
Polycythemia Vera
Besremi Approved for Adults With Polycythemia Vera
Besremi is a monopegylated, long-acting interferon, which exhibits its cellular effects in the bone marrow in polycythemia vera.
Myeloproliferative Neoplasms: What Your Patients Need to Know
Myeloproliferative neoplasms (MPN) are a rare form of blood cancer. Though most people don’t know a lot about, approximately 20,000 people develop MPNs each year. Here are the basics you can explain to a concerned patient.
- Loading...
Loading...
Next post in Chronic Myeloid Leukemia
Loading... 
Loading...